Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome

Clinical Endocrinology

Volumn 81, Issue 2, 2014, Pages 190-196

  Cheung, Evelyn Ning Man ^a   George, Susan R ^b   Costain, Gary A ^c   Andrade, Danielle M ^d   Chow, Eva W C ^a,b   Silversides, Candice K ^e,f,g   Bassett, Anne S ^a,b,e,f  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c SAINT JOHN REGIONAL HOSPITAL   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f TORONTO GENERAL HOSPITAL   (Canada)

^g MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; MAGNESIUM; PARATHYROID HORMONE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHROMOSOME DELETION 22Q11; CHROMOSOME DELETION 22Q11.2; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HORMONE RESPONSE; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; HYPOTHYROIDISM; LIFESPAN; LOGISTIC REGRESSION ANALYSIS; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; DIGEORGE SYNDROME; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; DIGEORGE SYNDROME; FEMALE; HUMANS; HYPOCALCEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84904390815     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12466     Document Type: Article

References (38)

1. Bassett, A.S., Chow, E.W.C., Husted, J., et al,. (2005) Clinical features of 78 adults with 22q11 deletion syndrome. American Journal of Medical Genetics. Part A, 138A, 307-313.
2. Scambler, P., (2000) The 22q11 deletion syndromes. Human Molecular Genetics, 9, 2421-2426.
3. Swillen, A., Vogels, A., Devriendt, K., et al,. (2000) Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. American Journal of Medical Genetics, 97, 128-135.
4. Bales, A.M., Zaleski, C.A., &, McPherson, E.W., (2010) Newborn screening programs: should 22q11 deletion syndrome be added? Genetics in Medicine, 12, 135-144.
5. Kobrynski, L.J., &, Sullivan, K.E., (2007) Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet, 370, 1443-1452.
6. Cuneo, B.F., Driscoll, D.A., Gidding, S.S., et al,. (1997) Evolution of latent hypoparathyroidism in familial 22q11 deletion syndrome. American Journal of Medical Genetics, 69, 50-55.
7. Scir, G., Dallapiccola, B., Iannetti, P., et al,. (1994) Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions. American Journal of Medical Genetics, 52, 478-482.
8. Choi, J.H., Shin, Y.L., Kim, G.H., et al,. (2005) Endocrine manifestations of chromosome 22q11.2 microdeletion syndrome. Hormone Research, 63, 294-299.
9. Ryan, A.K., Goodship, J.A., Wilson, D.I., et al,. (1997) Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. Journal of Medical Genetics, 34, 798-804.
10. Brauner, R., De Gonneville, A.L., Kindermans, C., et al,. (2003) Parathyroid function and growth in 22q11.2 deletion syndrome. Journal of Pediatrics, 142, 504-508.
11. Taylor, S.C., Morris, G., Wilson, D., et al,. (2003) Hypoparathyroidism and 22q11 deletion syndrome. Archives of Disease in Childhood, 88, 520-522.
12. Weinzimer, S.A., (2001) Endocrine aspects of the 22q11.2 deletion syndrome. Genetics in Medicine, 3, 19-22.
13. Bilezikian, J.P., Khan, A., Potts, J.T. Jr, et al,. (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. Journal of Bone and Mineral Research, 26, 2317-2337.
14. Eryol, N., Colak, R., Ozdogru, I., et al,. (2003) Effects of calcium treatment on QT interval and QT dispersion in hypocalcemia. American Journal of Cardiology, 91, 750-752.
15. Bassett, A.S., Costain, G., Fung, W.L.A., et al,. (2010) Clinically detectable copy number variations in a Canadian catchment population of schizophrenia. Journal of Psychiatric Research, 44, 1005-1009.
16. Fung, W.L.A., Chow, E.W.C., Webb, G.D., et al,. (2008) Extracardiac features predicting 22q11.2 Deletion Syndrome in adult congenital heart disease. International Journal of Cardiology, 131, 51-58.
17. Bassett, A.S., Chow, E.W.C., Husted, J., et al,. (2009) Premature death in adults with 22q11.2 deletion syndrome. Journal of Medical Genetics, 46, 324-330.
18. Driscoll, D.A., Salvin, J., Sellinger, B., et al,. (1993) Prevalence of 22q11 microdeletions in digeorge and velocardiofacial syndromes-implications for genetic-counseling and prenatal-diagnosis. Journal of Medical Genetics, 30, 813-817.
19. Bassett, A.S., Marshall, C.R., Lionel, A.C., et al,. (2008) Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Human Molecular Genetics, 17, 4045-4053.
20. Chow, E.W.C., Watson, M., Young, D.A., et al,. (2006) Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophrenia Research, 87, 270-278.
21. Cheung, E.N.M., George, S.R., Andrade, D.M., et al,. (2014) Neonatal hypocalcemia, neonatal seizures, and intellectual disability in 22q11.2 deletion syndrome. Genetics in Medicine, 16, 40-44.
22. Lima, K., Abrahamsen, T.G., Wolff, A.B., et al,. (2011) Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. European Journal of Endocrinology, 165, 345-352.
23. Stagi, S., Lapi, E., Gambineri, E., et al,. (2010) Thyroid function and morphology in subjects with microdeletion of chromosome 22q11 (del(22)(q11)). Clinical Endocrinology (Oxf), 72, 839-844.
24. Agus, Z., Wasserstein, A., &, Goldfarb, S., (1982) Disorders of calcium and magnesium homeostasis. American Journal of Medicine, 72, 473-488.
25. Jain, A., Agarwal, R., Sankar, M.J., et al,. (2010) Hypocalcemia in the newborn. Indian Journal of Pediatrics, 77, 1123-1128.
26. McGraw-Hill Medical. (2010) Harrison's Endocrinology, 2nd edn. McGraw-Hill Medical, New York.
27. Baron, R., &, Kenny, D., (1986) The moderator mediator variable distinction in social psychological-research-conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173-1182.
28. Bassett, A.S., McDonald-McGinn, D.M., Devriendt, K., et al,. (2011) Practical guidelines for managing patients with 22q11.2 deletion syndrome. Journal of Pediatrics, 159, 332-339.e1.
29. Maalouf, N., Sakhaee, K., &, Odvina, C., (2004) A case of chromosome 22q11 deletion syndrome diagnosed in a 32-year-old man with hypoparathyroidism. Journal of Clinical Endocrinology & Metabolism, 89, 4817-4820.
30. Al-Jenaidi, F., Makitie, O., Grunebaum, E., et al,. (2007) Parathyroid gland dysfunction in 22q11.2 deletion syndrome. Hormone Research, 67, 117-122.
31. McDonald-McGinn, D.M., Kirschner, R., Goldmuntz, E., et al,. (1999) The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genetic Counseling, 10, 11-24.
32. DiGeorge AM, (1965) Discussion on a new concept of the cellular basis of immunity. Journal of Pediatrics, 67, 907-908.
33. Conley, M.E., Beckwith, J.B., Mancer, J.F.K., et al,. (1979) Spectrum of the DiGeorge syndrome. Journal of Pediatrics, 94, 883-890.
34. Kapadia, C.R., Kim, Y.E., McDonald-McGinn, D.M., et al,. (2008) Parathyroid hormone reserve in 22q11.2 deletion syndrome. Genetics in Medicine, 10, 224-228.
35. Khan, S., (2007) Vitamin D deficiency and secondary hyperparathyroidism among patients with chronic kidney disease. American Journal of the Medical Sciences, 333, 201-207.
36. Medarov, B.I., (2009) Milk-Alkali syndrome. Mayo Clinic Proceedings, 84, 261-267.
37. Picolos, M., Lavis, V., &, Orlander, P., (2005) Milk-Alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients. Clinical Endocrinology (Oxf), 63, 566-576.
38. Rude, R., Oldham, S., &, Singer, F., (1976) Functional hypoparathyroidism and parathyroid-hormone end-organ resistance in human magnesium-deficiency. Clinical Endocrinology (Oxf), 5, 209-224.